z-logo
open-access-imgOpen Access
Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies
Author(s) -
Inna Sekirov,
Martin Petric,
Erin Carruthers,
David S. Lawrence,
Tamara Pidduck,
Jesse Kustra,
Jonathan Laley,
Min-Kuang Lee,
Navdeep Chahil,
Annie Mak,
Paul N. Levett,
Emelissa J. Mendoza,
Heidi Wood,
Mike Drebot,
Mel Krajden,
Muhammad Morshed
Publication year - 2021
Publication title -
access microbiology
Language(s) - English
Resource type - Journals
ISSN - 2516-8290
DOI - 10.1099/acmi.0.000257
Subject(s) - neutralization , virology , covid-19 , antibody , neutralizing antibody , coronavirus , virus , coronaviridae , biology , medicine , immunology , outbreak , infectious disease (medical specialty) , disease , pathology
We compared neutralization assays using either the wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus or surrogate neutralization markers, using characterized sera. We found the results of the neutralization assays 75 % concordant overall and 80 % concordant for samples with high antibody levels. This demonstrates that commercial surrogate SARS-CoV-2 assays offer the potential to assess anti-SARS-CoV-2 antibodies’ neutralizing capacity outside CL-3 laboratory containment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom